Refer A Patient

Request An Appointment

Neurology

LEQEMBI

LEQEMBI (lecanemab-irmb) is an amyloid beta-directed antibody indicated for treating Alzheimer’s disease.
Infusion or injection therapy referral
What it treats Alzheimer’s Disease
Prescribed by Neurologists
How it’s administered Intravenous (IV) infusion
Frequency Every two weeks
Length of treatment About one hour

About This Therapy

LEQEMBI (lecanemab-irmb) is an amyloid beta-directed antibody indicated for treating Alzheimer’s disease. LEQEMBI is intended to treat patients with mild cognitive impairment or experiencing the mild dementia stage of the disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

LEQEMBI REFERRAL FORM

LEQEMBI REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for LEQEMBI

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.